Sort publications on year
-
OthersPublic Health and Epidemiology
The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report
HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.
Therapie ; 2020;52(4),420-426
-
Public Health and Epidemiology
The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report.
HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.
Digestive and Liver Disease ; 2019
-
Pharmaco - Epidemiology
Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting.
BARBUT F, GALPERINE T, VANHEMS P, LE MONNIER A, DURAND-GASSELIN B, CANIS F, JEANBAT V, DUBURCQ A, ALAMI S, BENSOUSSAN C, FAGNANI F.
Health Qual Life Outcomes ; 2019;17(1);6
-
Pharmaco-Economics
Etude pharmaco-économique sur la prise en charge du reflux gastro-oesophagien en France en 2005 en médecine générale
MOULY S, CHARLEMAGNE A, LE JEUNNE PH, FAGNANI F
Presse Med ; 37:1397-1406
-
Pharmaco - Epidemiology
Irritable bowel syndrome in France : quality of life, medical management, and costs : the Encoli Study
BRUN-STRANG C, DAPOIGNY M, LAFUMA A, WAINSTEN JP, FAGNANI F
Eur J Gastroenterol Hepatol ; 19(12):1097-1103
-
Pharmaco - Epidemiology
EnquĂȘte nationale sur les pratiques de prophylaxie des hĂ©morragies gastroduodĂ©nales en rĂ©animation
DHOTE R, DETOURNAY B, SLAMA A, HAMEL L, BIGARD MA, BOLLAERT PE, COLIN R, FAGON JY, LE GALL JR, RAPHAEL JC
RĂ©animation Urgences ; 2000;9(7):550-554
-
Biometry and database analysis
Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis
BARBUT F, BOUEE S, LONGEPIERRE L, GOLDBERG M, BENSOUSSAN C, LEVY-BACHELOT L
J Hosp Infect ; 2017;98(1):21-28
-
Pharmaco - Epidemiology
Infliximab Paediatric Crohn’s Disease Educational Plan : A European, Cross-Sectional, Multicentre Evaluation
ARANA A, ALLEN S, BURKOWITZ J, FANTONI V, GHATNEKAR O, RICO MT, VANHAVERBEKE N, WENTWORTH CE, BROSA M, ARELLANO F
Drug Saf ; 2010;33(6):489-501
  Â